Larotrectinib API is a selective TRK inhibitor used in the treatment of NTRK gene fusion-positive solid tumors

Larotrectinib API is manufactured and supplied by ARTIS BIOTECH | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.